Cardiovascular disease: risk assessment and reduction, including lipid modification
KEYWORDS: people, cvd, risk, treatment, statin, statins, committee, recommendations, prevention, evidence, cholesterol, recommendation, lipid-lowering, primary, amended

lipid profile is needed on admission to hospital and 2 to 3 months after starting treatment. See the section on assessing response to treatment for further details. How the recommendations might affect practice These recommendations are in line with current practice and therefore will not have a resource impact. Return to recommendations Optimising statin treatment Recommendation 1.9.1 Why the committee made the recommendation The committee amended the 2014 consensus recommendation on what to do if someone taking statins does not reach their lipid target to apply to both the existing primary prevention target and the new secondary prevention target. The recommended actions remain the same. How the recommendation might affect practice The recommendation is in line with current practice and therefore will not have a resource impact. Return to recommendation Lipid target for secondary prevention of cardiovascular disease Recommendation 1.7.1, recommendations 1.7.7 to 1.7.10 and recommendations 1.10.3 and 1.10.4 Why the committee made the recommendations Lipid target The committee agreed LDL cholesterol and non-HDL cholesterol levels should be reduced as much as possible in people with CVD. However, people respond differently to statins and other lipid-lowering treatments, and it is not cost effective to offer the full range of treatments
